Two novel peptide vaccines, Aβ3-10-KLH and 5Aβ3-10, were developed.
Aβ3-10-KLH induced high levels of Aβ-specific antibodies in APP/PS1 transgenic mice.
Aβ3-10-KLH elicited Th2-polarized immune responses in APP/PS1 transgenic mice.
Aβ3-10-KLH inhibited cerebral Aβ deposition in APP/PS1 transgenic mice.
5Aβ3-10 did not induce effective humoral immune responses in APP/PS1 transgenic mice.